Financials
Half-year Report | Aug. 28, 2024 |
Annual Report and Accounts 2023 | Apr. 25, 2024 |
Final Results | Apr. 25, 2024 |
Half-year Report | Aug. 29, 2023 |
PRTC Final Results & Publication of Annual Report | Apr. 28, 2023 |
PRTC Final Results & Publication of Annual Report | Apr. 28, 2023 |
Half-year Report | Aug. 25, 2022 |
Proxies
Results of AGM on 13 June 2024 – Update Statement | Aug. 28, 2024 |
Result of AGM | Jun. 13, 2024 |
Proxy Form for 2024 AGM | Apr. 25, 2024 |
Notice of Meeting for 2024 AGM | Apr. 25, 2024 |
Result of AGM | Jun. 13, 2023 |
Notice of Meeting for 2023 AGM | Apr. 28, 2023 |
Proxy Form for 2023 AGM | Apr. 28, 2023 |
Ownership Update
Holding(s) in Company | Sep. 06, 2024 |
Holding(s) in Company | Jul. 01, 2024 |
PDMR Notification RSU Vesting | Jun. 27, 2024 |
Director/PDMR Shareholding | Jun. 27, 2024 |
Holding(s) in Company | Jun. 07, 2024 |
Transaction in Own Shares | Feb. 02, 2024 |
Transaction in Own Shares | Feb. 01, 2024 |
Announcements
PRTC's Vor Shares New AML Data Validating Approach | Sep. 06, 2024 |
PRTC Adds Industry Leader to Board of Directors | Aug. 22, 2024 |
Notice of Results | Aug. 21, 2024 |
PRTC's Seaport Appoints Global Pharma Exec to BOD | Aug. 13, 2024 |
PRTC'S Vedanta Expands Leadership Team | Jul. 23, 2024 |
Completion of Tender Offer & Total Voting Rights | Jun. 24, 2024 |
Result of Tender Offer | Jun. 24, 2024 |
Prospectuses
Offer of 67,599,621 Ordinary Shares at an offer price of 160 pence per Ordi | Jun. 19, 2015 |
Offer of 67,599,621 Ordinary Shares at an offer price of 160 pence per Ordi | Jun. 19, 2015 |